A detailed history of Tcfg Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tcfg Wealth Management, LLC holds 655 shares of LLY stock, worth $588,812. This represents 0.27% of its overall portfolio holdings.

Number of Shares
655
Previous 630 3.97%
Holding current value
$588,812
Previous $486 Million 11.23%
% of portfolio
0.27%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 16, 2025

BUY
$725.72 - $929.72 $18,143 - $23,243
25 Added 3.97%
655 $541 Million
Q4 2024

Jan 30, 2025

SELL
$727.2 - $932.06 $21,816 - $27,961
-30 Reduced 4.55%
630 $486 Million
Q3 2024

Oct 15, 2024

BUY
$772.14 - $960.02 $509,612 - $633,613
660 New
660 $585 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $854B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tcfg Wealth Management, LLC Portfolio

Follow Tcfg Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcfg Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcfg Wealth Management, LLC with notifications on news.